上集講述了PD1/PDL1在醫治癌細胞免疫治療方面的重要性，接下來我們將會繼續深入探討問題。1369Please respect copyright.ＰＥＮＡＮＡnogdFCQvCP
1369Please respect copyright.ＰＥＮＡＮＡYPQcLvIYeV
上集：https://www.penana.com/article/4711251369Please respect copyright.ＰＥＮＡＮＡNH52q5hxr6
1369Please respect copyright.ＰＥＮＡＮＡEeQwqLHnYZ
1369Please respect copyright.ＰＥＮＡＮＡarTgRwMonR
1369Please respect copyright.ＰＥＮＡＮＡTJQPOHrqNH
（圖1）雖然阻擋PD1/PDL1可以增強T cell辨認癌細胞的能力，但另一個重要的問題是，如何確保有足夠的T cell殺滅癌細胞呢?1369Please respect copyright.ＰＥＮＡＮＡrDTz0NcqIa
1369Please respect copyright.ＰＥＮＡＮＡ0bwGsCGSwh
就算成功糾正免疫系統細胞懂得把癌細胞辨認為外來之物，但免疫系統細胞數量不足的話，依然是不會達到重大效果的。1369Please respect copyright.ＰＥＮＡＮＡRX1j3h87Oj
1369Please respect copyright.ＰＥＮＡＮＡljGLLtDMBb
換句話說，我們需要一道能夠提升針對癌細胞的T cell數量手段。1369Please respect copyright.ＰＥＮＡＮＡbvXgVXP80t
1369Please respect copyright.ＰＥＮＡＮＡZZSKxWSboi
1369Please respect copyright.ＰＥＮＡＮＡIkMYJhaYPI
1369Please respect copyright.ＰＥＮＡＮＡ9lq3Y1fjEz
（圖2）T cell的產生數量，接近可以說是由Antigen Presenting Cells(APC)來決定;1369Please respect copyright.ＰＥＮＡＮＡEVRiKzm2yH
APC可以睇成為一堆負責把癌細胞獨特Neoantigen帶來T cell面前的細胞。1369Please respect copyright.ＰＥＮＡＮＡgAsZ71jRwn
1369Please respect copyright.ＰＥＮＡＮＡYPE3xWgyoO
忘記甚麼是Neoantigen的話，可重溫上一集。1369Please respect copyright.ＰＥＮＡＮＡ3JykxRoSGd
1369Please respect copyright.ＰＥＮＡＮＡaka93NipgX
當APC展示癌細胞的Neoantigen予T cell的receptor後，另一個必需的動作就是T cell表面的CD28與APC表面的B7合併。1369Please respect copyright.ＰＥＮＡＮＡuHp5mEhCaz
1369Please respect copyright.ＰＥＮＡＮＡdbiWTFbc8t
只要兩者條件達成的話，負責對付對應癌細胞的T cell數量及效力便會大增。1369Please respect copyright.ＰＥＮＡＮＡ8nVybpTZeq
1369Please respect copyright.ＰＥＮＡＮＡIPggPIe66h
1369Please respect copyright.ＰＥＮＡＮＡOnbntbfJav
1369Please respect copyright.ＰＥＮＡＮＡPEGZifw9J8
（圖3）然而，當T cell數量產生至一定程度的時候，T cell便會產生出CTLA4。CTLA4會搶奪CD28的位置，與B7合併。1369Please respect copyright.ＰＥＮＡＮＡObHrIrYwp6
1369Please respect copyright.ＰＥＮＡＮＡVMrQ8LHaaw
而當CTLA4與B7合併後，T cell所產生的數量及威力就會大減。1369Please respect copyright.ＰＥＮＡＮＡnQkLmrp2Xw
1369Please respect copyright.ＰＥＮＡＮＡe8c0dOb8ee
這個CTLA4產生的機制是與生俱來的，目的就是為了避免產生過量的T cell，以免身體會產生不良反應。1369Please respect copyright.ＰＥＮＡＮＡRRR8PSa6iQ
1369Please respect copyright.ＰＥＮＡＮＡxUnNI6w6O9
1369Please respect copyright.ＰＥＮＡＮＡnt6Mifv6pi
（圖4）只不過的是，現時癌細胞大敵當前，燃眉之急就是要調動大量的T cell前往討伐癌細胞。1369Please respect copyright.ＰＥＮＡＮＡ1WJvF4n3ae
1369Please respect copyright.ＰＥＮＡＮＡyHUaUW67bR
為此，我們重施應對PD1/PDL1故技，利用抗體阻擋CTLA4，確保CD28及B7持續合併，不斷產生效力高強的T cell。1369Please respect copyright.ＰＥＮＡＮＡhcaOselOYX
1369Please respect copyright.ＰＥＮＡＮＡZrEXSbKE96
1369Please respect copyright.ＰＥＮＡＮＡ3k6Aacouib
（圖5）簡略的總結來說，為了確保有足夠的T cell消滅癌細胞，我們不惜採用阻擋CTLA4的抗體，號令身體持續產生效力高強的T cell。1369Please respect copyright.ＰＥＮＡＮＡ93matdZlr4
而另一邊廂，我們亦同時利用阻擋PD1/PDL1的抗體，確保T cell能夠順利把癌細胞辨認成為外來物，將其制裁。1369Please respect copyright.ＰＥＮＡＮＡWfBj8zsdMg
1369Please respect copyright.ＰＥＮＡＮＡsRB9eVQU3D
這CTLA4抗體及PD1/PDL1抗體的雙管齊下療法，將能大大提升免疫治療的效率。1369Please respect copyright.ＰＥＮＡＮＡ3Npb6vY8wY
1369Please respect copyright.ＰＥＮＡＮＡ8TvPtLB9dh
但是，並不是所有病人也能依靠這方法而得益，原因是T cell沒法能夠順利抵達癌細胞的位置以及滲入癌細胞的內部作有效的消滅。1369Please respect copyright.ＰＥＮＡＮＡWkvLa5ArxM
1369Please respect copyright.ＰＥＮＡＮＡZ0CHbPllPk
這一方面，我們將會在下一篇免疫治療的最終章再作探討。1369Please respect copyright.ＰＥＮＡＮＡyt6NzDF74I
1369Please respect copyright.ＰＥＮＡＮＡzaZ9yd74SG
1369Please respect copyright.ＰＥＮＡＮＡzFc0wuNii6
如果想我快啲出文的話，請入去Penana網站科普專欄–薯不揀單俾一個like以及Bookmark，這對我非常之重要。1369Please respect copyright.ＰＥＮＡＮＡ7j6UBJhuPv
1369Please respect copyright.ＰＥＮＡＮＡCvchBGpumJ
Link: https://www.penana.com/story/66244/%E7%A7%91%E6%99%AE%E5%B0%88%E6%AC%84-%E8%96%AF%E4%B8%8D%E6%8F%80%E5%96%AE/toc1369Please respect copyright.ＰＥＮＡＮＡRUFCfNBdNM
1369Please respect copyright.ＰＥＮＡＮＡJ1woVQh1zc
同時亦可以在Penana網站裡按「買一嚿/半嚿薯仔」，以課金的方式推動我繼續搜羅資料寫文，多謝。1369Please respect copyright.ＰＥＮＡＮＡ0TtAd42N5e
1369Please respect copyright.ＰＥＮＡＮＡfbUkIiZWHZ
Link:1369Please respect copyright.ＰＥＮＡＮＡROZCoLTuYF
https://www.penana.com/user/27349/%E8%96%AF%E4%BB%94%E8%81%9E%E8%8C%B1%E8%8E%89/portfolio1369Please respect copyright.ＰＥＮＡＮＡQxRAC7B2Qy
1369Please respect copyright.ＰＥＮＡＮＡLu6WPyVbSH
1369Please respect copyright.ＰＥＮＡＮＡEKReH0GQM5
有興趣接收科普資訊的話，歡迎follow IG: potatopigtongue。1369Please respect copyright.ＰＥＮＡＮＡsUdp1Ce9t0
Penana
search
登入arrow_drop_down
註冊arrow_drop_down
